NewsRoom Articles - Page 21 of 154 - PsychedelicNewsWire (PNW)

WednesdayOct 11, 2023 3:12 pm

Study Explores Whether Social Workers, Psychiatrists, Psychologists Are Aligned Regarding Psychedelic-Assisted Therapy

A recent study from The Ohio State University’s Center for Psychedelic Drug Research sought to determine if psychiatrists, psychologists and social workers are on the same page regarding the swiftly growing psychedelic therapy field. The research team was specifically interested in assessing whether these providers were aligned about deploying psychedelics as treatments for various mental-health conditions. Psychedelic-based therapies are predicted to revolutionize the global psychiatry industry over the next couple of decades, thanks to the purported medical benefits of several psychedelic drugs. A growing body of scientific literature has connected numerous psychedelics to significant improvements in mental health, discovering that…

TuesdayOct 10, 2023 3:43 pm

Newsom Vetoes California Bill Seeking to Legalize Psychedelics

Governor Gavin Newsom of California has vetoed a measure that would legalize a number of psychedelics and establish a pathway for regulated access. In his message regarding the veto, the governor urged the legislature to present a new resolution in 2024 that created guidelines for regulated access to psychedelics for therapeutic use and also consider a possible framework for broader decriminalization in the future. Newsom added that while peer-reviewed research had shown that psychedelics could relieve suffering of individuals with conditions such as post-traumatic stress disorder and depression, guidelines on dosing and rules to prevent exploitation during guided therapy among…

MondayOct 09, 2023 11:02 am

Governor Signs Bill Allowing Doctors to Prescribe Federally Rescheduled Psychedelics

Last week, California Governor Gavin Newsom signed a resolution that would allow healthcare professionals in the state of California to prescribe MDMA, psilocybin and any other drugs classified under Schedule I to patients if and when the drugs were approved by the FDA for an exemption or reclassified to a lower schedule. The recently signed measure states that physicians, pharmacists or other authorized individuals who hold healing arts licenses and prescribe or dispense these drugs in accordance with federal regulations would be considered as acting in compliance with state law that governed the aforementioned acts. Currently, drugs classified under Schedule…

FridayOct 06, 2023 12:24 pm

Portland, Maine, Passes Resolution Decriminalizing Psychedelic Fungi and Plants

The city council in Portland, Mine, has passed a resolution to decriminalize psychedelic plants and fungi in the city. The council approved the measure to deprioritize law enforcement efforts against psychedelic fungi and plants in a 6 to 3 vote and adopted the resolution earlier this week. The measure is an amended version of a resolution passed by the Portland City Council Health and Human Services and Public Committee last month. According to the resolution, arresting and prosecuting Portland residents for the cultivation, possession, use or sharing of psychedelics will be of the lowest priority by the city’s law enforcement.…

ThursdayOct 05, 2023 3:56 pm

Scientists Concerned Chronic Psychedelic Microdosing Could Result in Valvular Heart Disease

A recent psychedelic study has left researchers concerned that chronic psychedelic microdosing could cause valvular heart disease. Psychedelics have exploded in popularity in recent years thanks to numerous claims of their medical efficacy, leading to an increase in psychedelic microdosing among the American population. Microdosing is the practice of taking very small doses of a psychedelic to gain some of its purported benefits, such as heightened creativity, better mental well-being and increased productivity, without experiencing any mind-bending effects. With a growing number of studies connecting various psychedelics to significant improvements against mental conditions such as depression, anxiety, eating disorders and…

WednesdayOct 04, 2023 4:02 pm

The Untold Story of Women’s Contributions to Psychedelics’ History

Psychedelics have taken over the mainstream public’s attention in recent years due to increasing reports on their potential mental-health benefits. A growing body of scientific literature has found that psychedelics may be effective at treating a plethora of mental-health conditions at small doses and with minimal side effects, prompting an explosion in public interest. However, with several states working to legalize therapeutic psychedelic use and amid nationwide efforts to develop psychedelic-based treatments, it seems the women who played a major role in psychedelics’ history have been overlooked. Initial research into psychedelics began more than 50 years ago when women such…

TuesdayOct 03, 2023 2:13 pm

More Psychiatrists View Use of Psychedelics in Treating Mental Disorders Positively

A recently published study has found that more than 80% of psychiatrists positively view the use of psychedelic substances in treating a range of mental-health conditions. For the study, researchers from different institutions including Case Western Reserve University, Harvard Medical School and Yale University School of Medicine, sent surveys to an estimated one thousand resident fellows and attending psychiatrists. Participants were required to assess statements on psychedelics, ranking them on a scale of strongly agree to strongly disagree. These statements included the use of psychedelics in treating substance-use disorders, the legalization of psychedelics for medical use and whether therapists would…

MondayOct 02, 2023 12:17 pm

Survey Suggests Psychedelics Are Effective Against Chronic Pain

A recent survey of over 150 volunteers has revealed that micro- and macrodoses of classic psychedelics may be able to alleviate chronic pain. Published in the “European Journal of Pain,” the study adds to the growing body of literature connecting psychedelics such as psilocybin (magic mushrooms), mescaline, DMT and LSD with reductions in chronic pain. Although the psychedelic research field is still in its infancy, most studies focus on the potential benefits and risks of using psychedelics to treat a myriad of mental-health issues. However, researchers have also discovered that psychedelics may also have applications in chronic pain treatment. In…

FridaySep 29, 2023 3:37 pm

Study Finds Psilocybin Users Less Inclined to Work Overtime

“Quiet quitting” is a phenomenon where employees put in the minimum effort, time and enthusiasm required of them at their jobs and don’t go out of their way to create any extra value for their employers. The trend has picked up a lot of steam in recent years as employees have begun prioritizing a strict work-life balance and finding value in their hobbies and other experiences rather than work. Increased employee demands and stagnating wages coupled with increasing living costs have made many employees question if going the extra mile, whether it's through arriving early, taking part in nonmandatory meetings…

ThursdaySep 28, 2023 2:45 pm

Report Forecasts $7.2B Market for Psychedelics by 2029

Psychedelics are projected to enjoy a compound annual growth rate (CAGR) of 55% and achieve a $7.2 billion valuation by 2029. A recent report from data and analytics firm GlobalData revealed that the psychedelic drug market is poised to experience robust growth before the end of the decade thanks to positive developments on the legislative and regulatory side. The past couple of years have seen an exponential rise in public and scientific psychedelic interest thanks to a plethora of studies associating hallucinogens such as psilocybin, LSD and ayahuasca with significant improvements in mental health. A growing body of research has…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000